Carfilzomib Combined with Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients with Multiple Myeloma: 8 Vs 4 Induction Cycles; the Carthadex Trial
HemaSphere(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要